Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.

Wei G, Sun Z, Gao Y, Heng J, Lu W, Zou Z

Open source

DOI
10.1039/d6md00403b
Published
2026 Jun 24
Container
RSC medicinal chemistry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6md00403b,
  title = {Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.},
  author = {Wei G and Sun Z and Gao Y and Heng J and Lu W and Zou Z},
  year = {2026},
  journal = {RSC medicinal chemistry},
  doi = {10.1039/d6md00403b},
  url = {https://doi.org/10.1039/d6md00403b}
}

RIS

TY  - JOUR
TI  - Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.
AU  - Wei G
AU  - Sun Z
AU  - Gao Y
AU  - Heng J
AU  - Lu W
AU  - Zou Z
PY  - 2026
JO  - RSC medicinal chemistry
DO  - 10.1039/d6md00403b
UR  - https://doi.org/10.1039/d6md00403b
ER  - 

APA

G, W., Z, S., Y, G., J, H., W, L., & Z, Z. (2026). Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.. RSC medicinal chemistry. https://doi.org/10.1039/d6md00403b

Source records